Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peritoneal access for intracavitary chemotherapy.

S B Howell, C E Pfeifle

    Cancer Drug Delivery
    |January 1, 1986
    PubMed
    Summary

    Directly administering chemotherapy into the peritoneum increases drug exposure for ovarian cancer and mesothelioma. Totally implanted systems like Port-a-Cath reduce risks and improve patient acceptance, though catheter blockage by adhesions is a challenge.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A resonant sextuplet of sub-Neptunes transiting the bright star HD 110067.

    Nature·2023
    Same author

    Antiparasitic efficacy of a novel plant-based functional food using an Ascaris suum model in pigs.

    Acta tropica·2014
    Same author

    Pharmacologic principles of intraperitoneal chemotherapy for the treatment of ovarian cancer.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2008
    Same author

    A novel approach for combining the use of in vitro and in vivo data to measure and detect emerging moxidectin resistance in gastrointestinal nematodes of goats.

    International journal for parasitology·2007
    Same author

    Improved targeting of platinum chemotherapeutics. the antitumour activity of the HPMA copolymer platinum agent AP5280 in murine tumour models.

    European journal of cancer (Oxford, England : 1990)·2004
    Same author

    Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolites.

    Annals of oncology : official journal of the European Society for Medical Oncology·2003

    Area of Science:

    • Oncology
    • Surgical Oncology
    • Drug Delivery Systems

    Background:

    • Intraperitoneal chemotherapy offers increased drug exposure for peritoneal cancers.
    • Traditional methods face challenges like bowel damage, infection, and poor patient acceptance.
    • Catheter-related complications, such as adhesions, hinder treatment efficacy.

    Purpose of the Study:

    • To evaluate the benefits of totally implanted access systems for intraperitoneal chemotherapy.
    • To compare patient acceptance and complication rates with externalized catheters.
    • To identify persistent challenges in intraperitoneal drug delivery systems.

    Main Methods:

    • Utilizing totally implanted access systems (e.g., Port-a-Cath) for drug delivery.
    • Comparing outcomes with traditional externalized catheters.
    • Monitoring for complications such as infection, bowel damage, and catheter obstruction.

    Main Results:

    • Totally implanted systems significantly reduce risks of bowel damage and infection.
    • Patient acceptance is notably higher compared to percutaneous catheters.
    • Catheter failure due to peritoneal adhesions remains a significant limitation.

    Conclusions:

    • Totally implanted systems offer a safer and more patient-friendly approach for intraperitoneal chemotherapy.
    • Addressing catheter adhesion is crucial for optimizing long-term treatment success.
    • Further innovation is needed to overcome mechanical failures in intraperitoneal access devices.

    Related Experiment Videos